Fibroblast growth factor 23 concentrations and modifying factors in children from age 12 to 24 months
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Folkhälsanin Tutkimussäätiö
- Novo Nordisk Fonden
- Sigrid Juséliuksen Säätiö
- Research Council of Finland
- Barncancerfonden
- Juho Vainion Säätiö
- Orionin Tutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
- Paulon Säätiö
- Finska Läkaresällskapet
- Instrumentariumin Tiedesäätiö
- Lastentautien Tutkimussäätiö
- Suomen Lääketieteen Säätiö
- Vetenskapsrådet
This publication has 29 references indexed in Scilit:
- Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR MiceJournal of Bone and Mineral Research, 2013
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in womenJournal of Bone and Mineral Research, 2013
- FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation studyInternational Journal of Pediatric Endocrinology, 2012
- Iron status and fibroblast growth factor-23 in Gambian childrenBone, 2012
- Regulation and Function of the FGF23/Klotho Endocrine PathwaysPhysiological Reviews, 2012
- Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy HumansThe Journal of Clinical Endocrinology & Metabolism, 2011
- New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-ageAnnals of Medicine, 2010
- Ferritin for the clinicianBlood Reviews, 2009
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Statistical Issues in Life Course EpidemiologyAmerican Journal of Epidemiology, 2005